Biohit Oyj - Changes board/management/auditors

Changes to Biohit Oyj’s management

Biohit Oyj August 26, 2013 at 10:30 a.m. local time (EET)



M.Sc. (Econ.) Jaana Mattila (b. 1966) has been appointed as Chief Financial
Officer (CFO) and a member of the management team of Biohit Oyj starting August
26, 2013. Before Biohit she has been Finance Director at Fazer Amica Oy and
worked in finance managerial positions at Stora Enso Oyj and Baxter Oy. 



Additional information:

CEO Semi Korpela, Biohit Oyj
tel. +358 9 773 861
investor.relations@biohit.fi
www.biohithealthcare.com



Biohit in brief

Biohit Oyj is a globally operating Finnish biotechnology company established in
1988. Biohit's mission is "Innovating for Health". The purpose of the company
is to take social responsibility and produce innovation, new technologies and
analysis systems for use in medicine, research institutions and industry,
helping to promote research and diagnostics and to improve the quality of life
of people by preventing disease, human suffering and financial loss. We are
committed to social responsibility and it is our duty to spread knowledge about
the Group I human carcinogen, acetaldehyde, and innovate and develop the
marketing and availability of our products and services. Biohit is
headquartered in Helsinki, Finland and its subsidiaries are located in China,
Italy and the United Kingdom. Since 1999, Biohit's series B shares (BIOBV) have
been listed in the NASDAQ OMX Helsinki Oy Small cap/Healthcare sector.
www.biohithealthcare.com